D57.452
Sickle-cell thalassemia beta plus with splenic sequestration
Clinical Classification Guidelines
Inclusion Terms
- HbS-beta plus with splenic sequestration
- Sickle-cell beta plus with splenic sequestration
Medical Intelligence & Overview
Sickle-cell thalassemia beta plus with splenic sequestration is a complex blood disorder involving abnormal hemoglobin production and sudden trapping of blood cells in the spleen. This condition is a variation of sickle cell disease combined with certain types of thalassemia, leading to a range of health issues that require medical attention and management. The condition is classified under ICD-10 code D57.452 and typically manifests with episodes that can threaten life if not promptly managed.
Causes & Symptoms
Clinical Causes: Inheritance of sickle cell trait or disease along with beta thalassemia mutations Genetic mutations affecting hemoglobin production, specifically leading to defective hemoglobin S and beta globin chains The abnormal hemoglobin causes red blood cells to become rigid and sickle-shaped, which predisposes them to get trapped in the spleen
Key Symptoms: Sudden enlargement or swelling of the spleen (splenic sequestration), often causing abdominal pain Rapid drop in hemoglobin levels leading to anemia symptoms such as fatigue, pallor, or shortness of breath Episodes of severe pain across various parts of the body, known as sickling crises Fever or signs of infection, as the spleen plays a role in fighting infections Jaundice or yellowing of the skin, indicating rapid breakdown of red blood cells Weakness or dizziness during or following splenic sequestration episodes
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of blood tests and clinical evaluation. Key steps include:
Treatment Protocols: Management involves both prevention and treatment of acute episodes, tailored to the patient's needs. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is D57.452 a billable ICD-10 code?
Yes, D57.452 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D57.452?
Clinical documentation must specify the nature of Sickle-cell thalassemia beta plus with splenic sequestration and any associated comorbidities for accurate reporting.
Cite this Clinical Reference